Importer of Controlled Substances Registration: Johnson Matthey, Inc., 22638 [2016-08847]
Download as PDF
22638
Federal Register / Vol. 81, No. 74 / Monday, April 18, 2016 / Notices
The company plans to import small
quantities of the listed controlled
substances for the National Institute on
Drug Abuse (NIDA) for research
activities.
The company plans to import
analytical reference standards for
distribution to its customers for research
and analytical purposes. Placement of
these drug codes onto the company’s
registration does not translate into
automatic approval of subsequent
permit applications to import controlled
substances. Approval of permit
applications will occur only when the
registrant’s business activity is
consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization
will not extend to the import of FDA
approved or non-approved finished
dosage forms for commercial sale.
Dated: April 11, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–08842 Filed 4–15–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration: Johnson Matthey, Inc.
ACTION:
Notice of registration.
Johnson Matthey, Inc. applied
to be registered as an importer of certain
basic classes of controlled substances.
The Drug Enforcement Administration
(DEA) grants Johnson Matthey, Inc.
registration as an importer of those
controlled substances.
SUPPLEMENTARY INFORMATION: By notice
dated December 21, 2015, and
published in the Federal Register on
December 29, 2015, 80 FR 81367,
Johnson Matthey, Inc., Pharmaceutical
Materials, 2003 Nolte Drive, West
Deptford, New Jersey 08066–1742
applied to be registered as an importer
of certain basic classes of controlled
substances. Comments and request for
hearings on applications to import
narcotic raw material are not
appropriate. 72 FR 3417, (January 25,
2007). Also no comments or objections
were submitted for this notice.
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of
Johnson Matthey, Inc. to import the
basic classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:54 Apr 15, 2016
Jkt 238001
protocols in effect onMay 1, 1971. The
DEA investigated the company’s
maintenance of effective controls
against diversion by inspecting and
testing the company’s physical security
systems, verifying the company’s
compliance with state and local laws,
and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of the following basic classes
of controlled substances:
Controlled substance
Coca Leaves (9040) .....................
Thebaine (9333) ...........................
Opium, raw (9600) .......................
Noroxymorphone (9668) ..............
Poppy Straw Concentrate (9670)
Fentanyl (9801) ............................
Schedule
II
II
II
II
II
II
The company plans to import
thebaine derivatives and fentanyl as
reference standards.
The company plans to import the
remaining listed controlled substances
as raw materials, to be used in the
manufacture of bulk controlled
substances, for distribution to its
customers. Placement of these drug
codes onto the company’s registration
does not translate into automatic
approval of subsequent permit
applications to import controlled
substances.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of FDA approved or nonapproved finished dosage forms for
commercial sale.
Dated: April 11, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–08847 Filed 4–15–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration: Meridian Medical
Technologies
ACTION:
Notice of registration.
Meridian Medical
Technologies applied to be registered as
an importer of a certain basic class of
controlled substance. The Drug
SUMMARY:
PO 00000
Frm 00072
Fmt 4703
Sfmt 9990
Enforcement Administration (DEA)
grants Meridian Medical Technologies
registration as an importer of this
controlled substance.
By notice
dated November 27, 2015, and
published in the Federal Register on
December 3, 2015, 80 FR 75691,
Meridian Medical Technologies, 2555
Hermelin Drive, Saint Louis, Missouri
63144 applied to be registered as an
importer of a certain basic class of
controlled substance. No comments or
objections were submitted for this
notice.
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of
Meridian Medical Technologies to
import the basic class of controlled
substance is consistent with the public
interest and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971. The DEA investigated the
company’s maintenance of effective
controls against diversion by inspecting
and testing the company’s physical
security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of morphine (9300), a basic
class of controlled substance listed in
schedule II.
The company manufactures a product
containing morphine in the United
States. The company exports this
product to customers around the world.
The company has been asked to ensure
that its product, which is sold to
European customers, meets the
standards established by the European
Pharmacopeia, administered by the
Directorate for the Quality of Medicines
(EDQM). In order to ensure that its
product will meet European
specifications, the company seeks to
import morphine supplied by EDQM for
use as reference standards.
This is the sole purpose for which the
company will be authorized by the DEA
to import morphine.
SUPPLEMENTARY INFORMATION:
Dated: April 11, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–08844 Filed 4–15–16; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\18APN1.SGM
18APN1
Agencies
[Federal Register Volume 81, Number 74 (Monday, April 18, 2016)]
[Notices]
[Page 22638]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-08847]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration: Johnson Matthey,
Inc.
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Johnson Matthey, Inc. applied to be registered as an importer
of certain basic classes of controlled substances. The Drug Enforcement
Administration (DEA) grants Johnson Matthey, Inc. registration as an
importer of those controlled substances.
SUPPLEMENTARY INFORMATION: By notice dated December 21, 2015, and
published in the Federal Register on December 29, 2015, 80 FR 81367,
Johnson Matthey, Inc., Pharmaceutical Materials, 2003 Nolte Drive, West
Deptford, New Jersey 08066-1742 applied to be registered as an importer
of certain basic classes of controlled substances. Comments and request
for hearings on applications to import narcotic raw material are not
appropriate. 72 FR 3417, (January 25, 2007). Also no comments or
objections were submitted for this notice.
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the registration of Johnson Matthey, Inc. to
import the basic classes of controlled substances is consistent with
the public interest and with United States obligations under
international treaties, conventions, or protocols in effect onMay 1,
1971. The DEA investigated the company's maintenance of effective
controls against diversion by inspecting and testing the company's
physical security systems, verifying the company's compliance with
state and local laws, and reviewing the company's background and
history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the above-named company is granted
registration as an importer of the following basic classes of
controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Coca Leaves (9040)......................... II
Thebaine (9333)............................ II
Opium, raw (9600).......................... II
Noroxymorphone (9668)...................... II
Poppy Straw Concentrate (9670)............. II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to import thebaine derivatives and fentanyl as
reference standards.
The company plans to import the remaining listed controlled
substances as raw materials, to be used in the manufacture of bulk
controlled substances, for distribution to its customers. Placement of
these drug codes onto the company's registration does not translate
into automatic approval of subsequent permit applications to import
controlled substances.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of FDA approved or non-approved finished dosage forms for commercial
sale.
Dated: April 11, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-08847 Filed 4-15-16; 8:45 am]
BILLING CODE 4410-09-P